Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient

European Journal of Dermatology

Volumn 12, Issue 2, 2002, Pages 194-197

  Heinzerling, Lucie ^a   Dummer, Reinhard ^a   Burg, Günter ^a   Schmid Grendelmeier, Peter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adverse event; Injection site reaction; Interferon beta; Multiple sclerosis; Septal panniculitis

Indexed keywords

BETA1A INTERFERON; DOXYCYCLINE; INTERFERON BETA SERINE; RECOMBINANT BETA INTERFERON; TRIAMCINOLONE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INJECTION SITE; MULTIPLE SCLEROSIS; PAIN; PANNICULITIS; QUALITY OF LIFE; SKIN BIOPSY;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PANNICULITIS;

EID: 0036191371     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons
2. Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma
3. Clinica significance of: Anti-IFN-a pha antibody titers during interferon therapy
4. Adjuvant immunotherapy in malignant melanoma: Impact of antibody formation against interferon-alpha on immunoparameters in vivo
5. Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy
6. Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial
7. Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients
8. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b
9. Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis
10. Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis
11. Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum
12. Cutaneous necrosis associated with recombinant interferon injection
13. Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection
14. Nécrose cutanée locale après injections d'interferon bêta
15. Cutaneous ulceration after injection of polyethylene glycol (PEG) modified-interferon alpha associated with visual disturbances in a melanoma patient
16. Aseptische hautnekrose nach subkutaner injektion von interferon-α
17. Cutaneous local necrosis following interferon injections
18. Cutaneous ulcerations secondary to interferon-α therapy of Kaposi's sarcoma
19. Cutaneous necrosis caused by injection of alpha-interferon in a patient with chronic myelogenous leukemia
20. Cutaneous necrosis by subcutaneous injection of α-interferon in a patient with chronic type B hepatitis
21. Cutaneous necrosis associated with interferon alfa-2b
22. Septal panniculitis induced by atenolol-a case report
23. Lobular panniculitis associated with ciprofloxacin
24. Recurrent panniculitis in a patient receiving protease inhibitor therapy for human immunodeficiency virus infection
25. Panniculitis in association with apomorphine infusion
26. Panniculitis. Part I. Mostly septal panniculitis
27. Histiocytic cytophagic panniculitis which developed during interferon-alpha therapy
28. Multiple sclerosis-side effects of interferon beta therapy and their management
29. Local reactions after subcutaneous injections of α-interferon
30. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis
31. Interferon beta-1b injection site reactions and necroses
32. Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2
33. Panniculitis (Rothmann-Makai), with good response to tetracycline
34. An unusual panniculitis appearing in the winter with good response to tetracycline
35. Septal panniculitis as a manifestation of Lyme disease
36. The use of anti-collagenase properties of doxycycline in treatment of α1-antitrypsin deficiency panniculitis
37. Panniculitis due to α1-antitrypsin deficiency induced by cryosurgery
38. Specificity of the anticollagenase action of tetracyclines: Relevance to their anti-inflammatory potential
39. Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro